RBC Europe’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$35K Hold
1,068
﹤0.01% 362
2022
Q1
$77K Hold
1,068
﹤0.01% 312
2021
Q4
$98K Buy
1,068
+433
+68% +$51.8K ﹤0.01% 285
2021
Q3
$80.5K Buy
635
+67
+12% +$9.75K ﹤0.01% 459
2021
Q2
$94.5K Sell
568
-110
-16% -$17.8K ﹤0.01% 444
2021
Q1
$123K Sell
678
-619
-48% -$144K 0.01% 368
2020
Q4
$259K Buy
1,297
+507
+64% +$103K 0.01% 246
2020
Q3
$173K Sell
790
-60
-7% -$12.7K 0.01% 270
2020
Q2
$162K Sell
850
-575
-40% -$101K 0.01% 271
2020
Q1
$221K Buy
1,425
+60
+4% +$6.98K 0.02% 199
2019
Q4
$114K Hold
1,365
0.01% 320
2019
Q3
$92.4K Sell
1,365
-125
-8% -$8.23K 0.01% 347
2019
Q2
$99K Hold
1,490
0.01% 340
2019
Q1
$82.8K Buy
1,490
+312
+26% +$19K 0.01% 363
2018
Q4
$58.4K Buy
1,178
+258
+28% +$15.8K 0.01% 406
2018
Q3
$79.4K Sell
920
-203
-18% -$14.5K 0.01% 390
2018
Q2
$65.2K Buy
1,123
+304
+37% +$14.8K 0.01% 421
2018
Q1
$33K Buy
819
+278
+51% +$10.5K ﹤0.01% 561
2017
Q4
$18.9K Buy
541
+399
+281% +$13.3K ﹤0.01% 690
2017
Q3
$4.71K Buy
+142
New +$4.66K ﹤0.01% 959

Other funds holding TDOC

RBC Europe's TDOC Position: Q2 2022 in Review

RBC Europe held its Teladoc Health (TDOC) position steady in Q2 2022 at 1,068 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

RBC Europe first reported a position in TDOC in Q3 2017 and has held it in 20 quarters since. The position peaked at $259K in Q4 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • RBC Europe held 1,068 shares of Teladoc Health worth $35K as of Q2 2022.
  • RBC Europe left its Teladoc Health share count unchanged in Q2 2022.
  • Teladoc Health made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #362 holding.
  • RBC Europe first reported a position in Teladoc Health in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Teladoc Health position peaked at $259K in Q4 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.